Wegovy may be valuable new option for heart failure patients

by

Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

Leave A Comment

Your email address will not be published. Required fields are marked *